The deal gives Bio-Rad licensing rights to a PCR-based platform and an assay that improves diagnostic sensitivity and efficacy across four dengue serotypes.
The College Station, Texas-based firm is developing a multiplex, one-step system to diagnose all four dengue serotypes.
The automated device was able to detect pathogens from clinical samples and can be built from a 3D printer retailing at $750 or less.
The firm expands its portfolio, providing customers with Dx for multiple applications
The US Food and Drug Administration has granted Emergency Use Authorization to a real-time PCR test for Dengue, chikungunya, and Zika viruses.
In PLOS this week: metabolomics signature of dengue disease progression, patterns of diversity in Pseudomonas fluorescens, and more.
The South Korean company said the kit not only detects Zika, but is also set up to find multiple mosquito-borne diseases such as Dengue and Chikunguya.
The firm has improved design of the system for low-resource settings and validated it on clinical chlamydia samples and extracted HIV, Ebola, and dengue samples.
In PLOS this week: variant differences between scout and recruit bees, intra-host MERS-CoV diversity, and more.
The researchers are using an NIH grant to develop a device to discriminate various fever-causing viruses endemic to West Africa and Plasmodium falciparum.
In Nucleic Acids Research this week: ProTraits includes genetic, phenotypic data on bacteria, archaea; Candida albicans assembly 22; and more.
The Wall Street Journal reports that researchers are looking beyond Cas9 for CRISPR editing.
Familial DNA searches in criminal cases are winning over some critics, the Los Angeles Times reports.
Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.